The Regional Medical Center’s Dialysis Access Institute demonstrated a variety of dialysis access procedures via satellite to attendees of the 2019 Vascular Access Surgery Association Practicum held ...
RAS(ON) Inhibitor Combination Studies: RMC-6236 with Pembrolizumab: RMC-LUNG-101B is an arm of the Phase 1b study of RMC-6236 in combination with pembrolizumab, with or without chemotherapy, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results